Noticias de INSM_US

Noticias del mercado

Últimas noticias sobre INSM_US — 189 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: INSM_US ✕ 189 resultados
31/03/2026 INSM_US — Stock Titan
INSMED (INSM) CLO exercises options and sells 19,638 shares under 10b5-1 plan
30/03/2026 INSM_US — Insider Monkey
10 Stocks Leaving the Market in the Dust Today: Insmed, FMC, Alcoa, and More
30/03/2026 INSM_US — Yahoo Finance
Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?
30/03/2026 INSM_US — Stock Titan
[144] INSMED Inc SEC Filing
30/03/2026 INSM_US — Yahoo Finance
Insmed (INSM) Jumps as Morgan Stanley Raises PT by 28%
30/03/2026 INSM_US — Investing.com
Leerink reiterates Insmed stock rating on TPIP franchise potential
27/03/2026 INSM_US — Stock Titan
Vanguard disaggregates holdings; Insmed (NASDAQ: INSM) shows 0 shares
26/03/2026 INSM_US — GuruFocus
INSM Stock: HC Wainwright & Co. Raises Price Target to $245 | IN
24/03/2026 INSM_US — TradingView
INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study
23/03/2026 INSM_US — Benzinga
Insmed Lung Infection Therapy Data Impresses, Analyst Sees Approval Path
23/03/2026 INSM_US — GuruFocus
Insmed (INSM): Wells Fargo Lowers Price Target While Maintaining
23/03/2026 INSM_US — Stock Titan
ENCORE success positions Insmed (Nasdaq: INSM) to seek ARIKAYCE label expansion
23/03/2026 INSM_US — Investing.com
Insmed reports positive Phase 3b trial results for MAC lung disease drug
23/03/2026 INSM_US — Yahoo Finance
Insmed ENCORE Phase 3 Trial Hits Primary Endpoint; ARIKAYCE Drives Strong MAC Culture Conversion Gains
23/03/2026 INSM_US — Stock Titan
Insmed says inhaled MAC drug improved symptoms and culture conversion
23/03/2026 INSM_US — GuruFocus
Insmed (INSM) Achieves Positive Results in Phase 3b Study for AR
23/03/2026 INSM_US — GuruFocus
Insmed (INSM) Achieves Milestone with Positive Phase 3 ENCORE Tr
23/03/2026 INSM_US — GuruFocus
Insmed (INSM) Shares Surge Following Positive Phase 3b Study Res
21/03/2026 INSM_US — MSN ES ← EN
Insmed (INSM) está preparado para un aumento en 2026 con un potencial aumento de ventas de Arikayce de 1.300 millones de dólares, Roth/MKM inicia la compra
20/03/2026 INSM_US — Investing.com
Insmed chair and CEO Lewis sells $1.5M in shares

Página 8 de 10

keyboard_arrow_up